Smoldering mantle cell lymphoma

BACKGROUND: Mantle cell lymphoma (MCL) is an aggressive disease, with poor prognosis and a limited survival. However, some patients with indolent MCL can survive beyond 7~10 years. These patients remain largely asymptomatic and can be in observation for a long time without any treatment. The process...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Haige, Desai, Aakash, Zeng, Dongfeng, Nomie, Krystle, Romaguera, Jorge, Ahmed, Makhdum, Wang, Michael L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732450/
https://www.ncbi.nlm.nih.gov/pubmed/29246179
http://dx.doi.org/10.1186/s13046-017-0652-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732450/
https://www.ncbi.nlm.nih.gov/pubmed/29246179
http://dx.doi.org/10.1186/s13046-017-0652-8

Ejemplares similares